Erypnos 4000IU Injection

Prezentare produs

About Erypnos 4000IU Injection

Erypnos 4000IU Injection is a sterile, injectable medicinal product formulated for clinical use. It is classified as a therapeutic agent designed to support the production of red blood cells within the body. This medication is typically administered under the direct supervision of a qualified healthcare professional in a clinical or hospital setting. Patients should ensure that the product is stored according to the specific temperature requirements provided on the packaging to maintain its stability and efficacy. It is essential to follow the precise dosage schedule prescribed by a physician to ensure safe and appropriate treatment outcomes.

Key Benefits & Uses

• Assists in the management of anemia associated with chronic kidney disease.
• Supports the stimulation of erythropoiesis in patients undergoing specific medical therapies.
• Helps maintain adequate hemoglobin levels as determined by clinical diagnostic testing.

Active Ingredient & Action

The active ingredient in this medication is Recombinant Human Erythropoietin Alfa. This substance functions as a synthetic version of the naturally occurring hormone produced by the kidneys. It acts by stimulating the bone marrow to increase the production of red blood cells, which are vital for oxygen transport throughout the circulatory system.

Important Notes

Erypnos 4000IU Injection must be administered strictly according to medical instructions. Do not use this product if the solution appears cloudy or contains visible particles. Always consult with a healthcare provider regarding any pre-existing medical conditions or potential contraindications before beginning treatment.